3R2F image
Deposition Date 2011-03-14
Release Date 2011-08-31
Last Version Date 2024-11-27
Entry Detail
PDB ID:
3R2F
Title:
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with BMS-693391 AKA (2S)-2-((3R)-3-acetamido-3-isobutyl-2-oxo-1-pyrrolidinyl)-N-((1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-2-((2R,4R)-4-propoxy-2-pyrrolidinyl)ethyl)-4-phenylbutanamide
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.53 Å
R-Value Free:
0.33
R-Value Work:
0.28
R-Value Observed:
0.28
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Beta-secretase 1
Gene (Uniprot):BACE1
Chain IDs:A, B, C (auth: D), D (auth: E)
Chain Length:455
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Monosubstituted {gamma}-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of {beta}-secretase (BACE).
Bioorg.Med.Chem.Lett. 21 6916 6924 (2011)
PMID: 21782431 DOI: 10.1016/j.bmcl.2011.06.109

Abstact

The synthesis, evaluation, and structure-activity relationships of a class of γ-lactam 1,3-diaminopropan-2-ol transition-state isostere inhibitors of BACE are discussed. Two strategies for optimizing lead compound 1a are presented. Reducing the overall size of the inhibitors resulted in the identification of γ-lactam 1i, whereas the introduction of conformational constraint on the prime-side of the inhibitor generated compounds such as the 3-hydroxypyrrolidine inhibitor 28n. The full in vivo profile of 1i in rats and 28n in Tg 2576 mice is presented.

Legend

Protein

Chemical

Disease

Primary Citation of related structures